SCHEMBL28297743

SCHEMBL28297743

O=Cc1cccc(-c2cccc([N+](=O)[O-])c2F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALDH5A1 P51649 1/20 0.43
ABAT P80404 1/20 0.43
VCAM1 P19320 1/20 0.43
MAPT P10636 6/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
ERN1 O75460 1/20 0.40
S100A4 P26447 2/20 0.39
XDH P47989 2/20 0.39
FBP1 P09467 1/20 0.39
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
ALDH3A1 P30838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1999472 0.79 ALDH1A1 (0.69) ALDH1A1TDP1MAPTMEN1KMT2A
SCHEMBL6797781 0.79 TDP1 (0.46) ALDH1A1TDP1MAPTMEN1KMT2A
SCHEMBL26704116 0.78 TRIM24 (0.44) ALDH1A1CA12CA1CA2CA9
SCHEMBL2000140 0.75 EIF4E (0.45) ALDH1A1TDP1VCAM1MEN1KMT2A
SCHEMBL13482044 0.75 ERN1 (0.51) ALDH1A1TDP1MAPTLMNAERN1
SCHEMBL28891805 0.73 TRIM24 (0.42) ALDH1A1CA12CA1CA2CA9
SCHEMBL5490744 0.73 TRIM24 (0.52) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL5733634 0.73 KIF11 (0.43) ALDH1A1CA12CA1CA2CA9
SCHEMBL13483001 0.73 PTPRC (0.47) ALDH1A1CA12CA1CA2CA9
SCHEMBL31491413 0.73 PTPRC (0.47) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-A Inhibitor as PARP1, PARP2 and/or tubulin can be used for the phthalazine derivatives for the treatment of cancer 加利福尼亚大学董事会 2019-06-04 CN disclosed